Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Kardiologia Polska (Polish Heart Journal)
MENU
Shortcuts Online first Submit an article Reviewers 2022 Zeszyty Edukacyjne Author Guidelines Licence terms

open access

Online first
Review paper
Published online: 2023-02-06
View PDF Download PDF file
Get Citation

How to predict conduction disturbances after transcatheter aortic valve replacement?

Laura Novelli12, Gulrays Jamie12, Damiano Regazzoli1, Bernhard Reimers1, Antonio Frontera12, Antonio Mangieri1
DOI: 10.33963/KP.a2023.0039
·
Pubmed: 36745533
Affiliations
  1. Humanitas Research Hospital IRCCS, Rozzano-Milan, Italy
  2. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy

open access

Online first
Review article
Published online: 2023-02-06

Abstract

Transcatheter aortic valve replacement (TAVI) has evolved into the gold standard management option for high-risk patients with severe aortic stenosis. Despite procedural, electrocardiographic and clinical predictors of important post-procedural conduction disturbances (left bundle branch block [LBBB] and high-degree atrioventricular block [HAVB]) being identified, and continuous technological refinement of transcatheter aortic valves, the rate of post-procedural conduction disturbance remains high, and challenging to manage. New strategies are required to reduce the overall rate of post-procedural PPI. In this article, we will review the incidence, predictive factors, and clinical implications of conduction disturbances after TAVI.

Abstract

Transcatheter aortic valve replacement (TAVI) has evolved into the gold standard management option for high-risk patients with severe aortic stenosis. Despite procedural, electrocardiographic and clinical predictors of important post-procedural conduction disturbances (left bundle branch block [LBBB] and high-degree atrioventricular block [HAVB]) being identified, and continuous technological refinement of transcatheter aortic valves, the rate of post-procedural conduction disturbance remains high, and challenging to manage. New strategies are required to reduce the overall rate of post-procedural PPI. In this article, we will review the incidence, predictive factors, and clinical implications of conduction disturbances after TAVI.

Full Text:

View PDF Download PDF file
Get Citation

Keywords

conduction disturbances, left bundle branch block, permanent pacemaker implantation, right bundle branch block, transcatheter aortic valve implantation

About this article
Title

How to predict conduction disturbances after transcatheter aortic valve replacement?

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Online first

Article type

Review paper

Published online

2023-02-06

Page views

61

Article views/downloads

85

DOI

10.33963/KP.a2023.0039

Pubmed

36745533

Keywords

conduction disturbances
left bundle branch block
permanent pacemaker implantation
right bundle branch block
transcatheter aortic valve implantation

Authors

Laura Novelli
Gulrays Jamie
Damiano Regazzoli
Bernhard Reimers
Antonio Frontera
Antonio Mangieri

References (80)
  1. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363(17): 1597–1607.
    CrossRefPubMed
  2. Yakubov SJ, Adams DH, Watson DR, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014; 63(19): 1972–1981.
    CrossRefPubMed
  3. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011; 364(23): 2187–2198.
    CrossRefPubMed
  4. Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016; 387(10034): 2218–2225.
    CrossRefPubMed
  5. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016; 374(17): 1609–1620.
    CrossRefPubMed
  6. Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017; 376(14): 1321–1331.
    CrossRefPubMed
  7. Pibarot P, Salaun E, Dahou A, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019; 380(18): 1695–1705.
    CrossRefPubMed
  8. Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019; 380(18): 1706–1715.
    CrossRefPubMed
  9. Huczek Z, Rymuza B, Mazurek M, et al. Temporal trends of transcatheter aortic valve implantation in a high-volume academic center over 10 years. Kardiol Pol. 2021; 79(7-8): 820–826.
    CrossRefPubMed
  10. Carroll JD, Vemulapalli S, Dai D, et al. Procedural Experience for Transcatheter Aortic Valve Replacement and Relation to Outcomes: The STS/ACC TVT Registry. J Am Coll Cardiol. 2017; 70(1): 29–41.
    CrossRefPubMed
  11. Vemulapalli S, Carroll JD, Mack MJ, et al. Procedural volume and outcomes for transcatheter aortic-valve replacement. N Engl J Med. 2019; 380(26): 2541–2550.
    CrossRefPubMed
  12. De Torres-Alba F, Kaleschke G, Diller GP, et al. Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation: The Critical Role of Valve Implantation Height. JACC Cardiovasc Interv. 2016; 9(8): 805–813.
    CrossRefPubMed
  13. Husser O, Pellegrini C, Kessler T, et al. Predictors of permanent pacemaker implantations and new-onset conduction abnormalities with the SAPIEN 3 balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv. 2016; 9(3): 244–254.
    CrossRefPubMed
  14. Meredith Am IT, Walters DL, Dumonteil N, et al. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study. J Am Coll Cardiol. 2014; 64(13): 1339–1348.
    CrossRefPubMed
  15. Khurshid S, Epstein AE, Verdino RJ, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Heart Rhythm. 2014; 11(9): 1619–1625.
    CrossRefPubMed
  16. Zannad F, Huvelle E, Dickstein K, et al. Left bundle branch block as a risk factor for progression to heart failure. Eur J Heart Fail. 2007; 9(1): 7–14.
    CrossRefPubMed
  17. Piazza N, de Jaegere P, Schultz C, et al. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv. 2008; 1(1): 74–81.
    CrossRefPubMed
  18. Mangieri A, Montalto C, Pagnesi M, et al. TAVI and post procedural cardiac conduction abnormalities. Front Cardiovasc Med. 2018; 5: 85.
    CrossRefPubMed
  19. Auffret V, Puri R, Urena M, et al. Conduction disturbances after transcatheter aortic valve replacement: current status and future perspectives. Circulation. 2017; 136(11): 1049–1069.
    CrossRefPubMed
  20. Tang GHL, Zaid S, Michev I, et al. "Cusp-Overlap" View Simplifies Fluoroscopy-Guided Implantation of Self-Expanding Valve in Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2018; 11(16): 1663–1665.
    CrossRefPubMed
  21. Corcione N, Berni A, Ferraro P, et al. Transcatheter aortic valve implantation with the novel-generation Navitor device: Procedural and early outcomes. Catheter Cardiovasc Interv. 2022; 100(1): 114–119.
    CrossRefPubMed
  22. Walther T, Manoharan G, Linke A, et al. Incidence of new-onset left bundle branch block and predictors of new permanent pacemaker following transcatheter aortic valve replacement with the Portico™ valve. Eur J Cardiothorac Surg. 2018; 54(3): 467–474.
    CrossRefPubMed
  23. Kroon HG, van Gils L, Ziviello F, et al. Impact of Baseline and Newly Acquired Conduction Disorders on Need for Permanent Pacemakers With 3 Consecutive Generations of Self-Expanding Transcatheter Aortic Heart Valves. Cardiovasc Revasc Med. 2022; 34: 40–45.
    CrossRefPubMed
  24. Tamburino C, Bleiziffer S, Thiele H, et al. Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis: SCOPE 2 Randomized Clinical Trial. Circulation. 2020; 142(25): 2431–2442.
    CrossRefPubMed
  25. Pellegrini C, Garot P, Morice MC, et al. Permanent pacemaker implantation and left bundle branch block with self-expanding valves - a SCOPE 2 subanalysis. EuroIntervention. 2022 [Epub ahead of print].
    CrossRefPubMed
  26. Möllmann H, Holzhey DM, Hilker M, et al. The ACURATE neo2 valve system for transcatheter aortic valve implantation: 30-day and 1-year outcomes. Clin Res Cardiol. 2021; 110(12): 1912–1920.
    CrossRefPubMed
  27. Chandra P, Jose J, Mattummal S, et al. Clinical evaluation of the Hydra self-expanding transcatheter aortic valve: 6 month results from the GENESIS trial. Catheter Cardiovasc Interv. 2021; 98(2): 371–379.
    CrossRefPubMed
  28. Moriyama N, Lehtola H, Miyashita H, et al. Hemodynamic comparison of transcatheter aortic valve replacement with the SAPIEN 3 Ultra versus SAPIEN 3: The HomoSAPIEN registry. Catheter Cardiovasc Interv. 2021; 97(7): E982–E991.
    CrossRefPubMed
  29. Mauri V, Reimann A, Stern D, et al. Predictors of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement With the SAPIEN 3. JACC Cardiovasc Interv. 2016; 9(21): 2200–2209.
    CrossRefPubMed
  30. Sammour Y, Banerjee K, Kumar A, et al. Systematic Approach to High Implantation of SAPIEN-3 Valve Achieves a Lower Rate of Conduction Abnormalities Including Pacemaker Implantation. Circ Cardiovasc Interv. 2021; 14(1): e009407.
    CrossRefPubMed
  31. Unzué L, García E, Díaz-Antón B, et al. Left Bundle Branch Block after Transcatheter Aortic Valve Implantation with Edwards Sapien 3 Valve: Influence of the Valve Depth Implantation. Cardiovasc Revasc Med. 2019; 20(11): 949–955.
    CrossRefPubMed
  32. Sammour YM, Lak H, Chahine J, et al. Clinical and echocardiographic outcomes with new-onset left bundle branch block after SAPIEN-3 transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2023; 101(1): 187–196.
    CrossRefPubMed
  33. Aggarwal SR, Clavel MA, Messika-Zeitoun D, et al. Sex differences in aortic valve calcification measured by multidetector computed tomography in aortic stenosis. Circ Cardiovasc Imaging. 2013; 6(1): 40–47.
    CrossRefPubMed
  34. Hamdan A, Barbash I, Schwammenthal E, et al. Sex differences in aortic root and vascular anatomy in patients undergoing transcatheter aortic valve implantation: A computed-tomographic study. J Cardiovasc Comput Tomogr. 2017; 11(2): 87–96.
    CrossRefPubMed
  35. Bleiziffer S, Ruge H, Hörer J, et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2010; 3(5): 524–530.
    CrossRefPubMed
  36. Regazzoli D, Chiarito M, Cannata F, et al. Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli: The TAVI-SMALL Registry. JACC Cardiovasc Interv. 2020; 13(2): 196–206.
    CrossRefPubMed
  37. Schymik G, Tzamalis P, Bramlage P, et al. Clinical impact of a new left bundle branch block following TAVI implantation: 1-year results of the TAVIK cohort. Clin Res Cardiol. 2015; 104(4): 351–362.
    CrossRefPubMed
  38. Giustino G, Van der Boon RMA, Molina-Martin de Nicolas J, et al. Impact of permanent pacemaker on mortality after transcatheter aortic valve implantation: the PRAGMATIC (Pooled Rotterdam-Milan-Toulouse in Collaboration) Pacemaker substudy. EuroIntervention. 2016; 12(9): 1185–1193.
    CrossRefPubMed
  39. Aslan S, Demir AR, Çelik Ö, et al. Usefulness of membranous septum length in the prediction of major conduction disturbances in patients undergoing transcatheter aortic valve replacement with different devices. Kardiol Pol. 2020; 78(10): 1020–1028.
    CrossRefPubMed
  40. Hamdan A, Guetta V, Klempfner R, et al. Inverse Relationship Between Membranous Septal Length and the Risk of Atrioventricular Block in Patients Undergoing Transcatheter Aortic Valve Implantation. JACC Cardiovasc Interv. 2015; 8(9): 1218–1228.
    CrossRefPubMed
  41. Hokken TW, Muhemin M, Okuno T, et al. Impact of membranous septum length on pacemaker need with different transcatheter aortic valve replacement systems: The INTERSECT registry. J Cardiovasc Comput Tomogr. 2022; 16(6): 524–530.
    CrossRefPubMed
  42. Maier O, Piayda K, Afzal S, et al. Computed tomography derived predictors of permanent pacemaker implantation after transcatheter aortic valve replacement: A meta-analysis. Catheter Cardiovasc Interv. 2021; 98(6): E897–E907.
    CrossRefPubMed
  43. Fujita B, Kütting M, Seiffert M, et al. Calcium distribution patterns of the aortic valve as a risk factor for the need of permanent pacemaker implantation after transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging. 2016; 17(12): 1385–1393.
    CrossRefPubMed
  44. Watanabe Y, Kozuma K, Hioki H, et al. Pre-Existing Right Bundle Branch Block Increases Risk for Death After Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve. JACC Cardiovasc Interv. 2016; 9(21): 2210–2216.
    CrossRefPubMed
  45. Auffret V, Webb JG, Eltchaninoff H, et al. Clinical Impact of Baseline Right Bundle Branch Block in Patients Undergoing Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2017; 10(15): 1564–1574.
    CrossRefPubMed
  46. Egger F, Nürnberg M, Rohla M, et al. High-degree atrioventricular block in patients with preexisting bundle branch block or bundle branch block occurring during transcatheter aortic valve implantation. Heart Rhythm. 2014; 11(12): 2176–2182.
    CrossRefPubMed
  47. Chorianopoulos E, Krumsdorf U, Pleger ST, et al. Incidence of late occurring bradyarrhythmias after TAVI with the self-expanding CoreValve(®) aortic bioprosthesis. Clin Res Cardiol. 2012; 101(5): 349–355.
    CrossRefPubMed
  48. Abu Rmilah AA, Al-Zu'bi H, Haq IU, et al. Predicting permanent pacemaker implantation following transcatheter aortic valve replacement: A contemporary meta-analysis of 981,168 patients. Heart Rhythm O2. 2022; 3(4): 385–392.
    CrossRefPubMed
  49. Fischer Q, Himbert D, Webb JG, et al. Impact of Preexisting Left Bundle Branch Block in Transcatheter Aortic Valve Replacement Recipients. Circ Cardiovasc Interv. 2018; 11(11): e006927.
    CrossRefPubMed
  50. Sammour Y, Sato K, Kumar A, et al. Impact of baseline conduction abnormalities on outcomes after transcatheter aortic valve replacement with SAPIEN-3. Catheter Cardiovasc Interv. 2021; 98(1): E127–E138.
    CrossRefPubMed
  51. Shoar S, Batra S, Gulraiz A, et al. Effect of pre-existing left bundle branch block on post-procedural outcomes of transcatheter aortic valve replacement: a meta-analysis of comparative studies. Am J Cardiovasc Dis. 2020; 10(4): 294–300.
    PubMed
  52. Urena M, Hayek S, Cheema AN, et al. Arrhythmia burden in elderly patients with severe aortic stenosis as determined by continuous electrocardiographic recording: toward a better understanding of arrhythmic events after transcatheter aortic valve replacement. Circulation. 2015; 131(5): 469–477.
    CrossRefPubMed
  53. Kiani S, Kamioka N, Black GB, et al. Development of a Risk Score to Predict New Pacemaker Implantation After Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2019; 12(21): 2133–2142.
    CrossRefPubMed
  54. Shivamurthy P, Vejpongsa P, Gurung S, et al. Validation of scoring system predicting permanent pacemaker implantation after transcatheter aortic valve replacement. Pacing Clin Electrophysiol. 2020; 43(5): 479–485.
    CrossRefPubMed
  55. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002; 106(24): 3006–3008.
    CrossRefPubMed
  56. Erkapic D, De Rosa S, Kelava A, et al. Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol. 2012; 23(4): 391–397.
    CrossRefPubMed
  57. Costa G, Saia F, Pilgrim T, et al. Transcatheter Aortic Valve Replacement With the Latest-Iteration Self-Expanding or Balloon-Expandable Valves: The Multicenter OPERA-TAVI Registry. JACC Cardiovasc Interv. 2022; 15(23): 2398–2407.
    CrossRefPubMed
  58. Siontis GCM, Jüni P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol. 2014; 64(2): 129–140.
    CrossRefPubMed
  59. Baggio S, Pagnesi M, Kim WK, et al. Comparison of transcatheter aortic valve replacement with the ACURATE neo2 versus Evolut PRO/PRO+ devices. EuroIntervention. 2023; 18(12): 977–986.
    CrossRefPubMed
  60. Lanz J, Kim WK, Walther T, et al. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial. Lancet. 2019; 394(10209): 1619–1628.
    CrossRefPubMed
  61. Husser O, Kim WK, Pellegrini C, et al. Multicenter Comparison of Novel Self-Expanding Versus Balloon-Expandable Transcatheter Heart Valves. JACC Cardiovasc Interv. 2017; 10(20): 2078–2087.
    CrossRefPubMed
  62. Lange P, Greif M, Vogel A, et al. Reduction of pacemaker implantation rates after CoreValve® implantation by moderate predilatation. EuroIntervention. 2014; 9(10): 1151–1157.
    CrossRefPubMed
  63. Auffret V, Regueiro A, Campelo-Parada F, et al. Feasibility, safety, and efficacy of transcatheter aortic valve replacement without balloon predilation: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2017; 90(5): 839–850.
    CrossRefPubMed
  64. Reul RM, Ramchandani MK, Reardon MJ. Transcatheter aortic valve-in-valve procedure in patients with bioprosthetic structural valve deterioration. Methodist Debakey Cardiovasc J. 2017; 13(3): 132–141.
    CrossRefPubMed
  65. Jilaihawi H, Zhao Z, Du R, et al. Minimizing permanent pacemaker following repositionable self-expanding transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2019; 12(18): 1796–1807.
    CrossRefPubMed
  66. Jilaihawi H, Zhao Z, Du R, et al. Minimizing permanent pacemaker following repositionable self-expanding transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2019; 12(18): 1796–1807.
    CrossRefPubMed
  67. Younis A, Orvin K, Nof E, et al. The effect of periprocedural beta blocker withdrawal on arrhythmic risk following transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2019; 93(7): 1361–1366.
    CrossRefPubMed
  68. Toggweiler S, Stortecky S, Holy E, et al. The electrocardiogram after transcatheter aortic valve replacement determines the risk for post-procedural high-degree AV block and the need for telemetry monitoring. JACC Cardiovasc Interv. 2016; 9(12): 1269–1276.
    CrossRefPubMed
  69. Guetta V, Goldenberg G, Segev A, et al. Predictors and course of high-degree atrioventricular block after transcatheter aortic valve implantation using the CoreValve Revalving System. Am J Cardiol. 2011; 108(11): 1600–1605.
    CrossRefPubMed
  70. Massoullié G, Bordachar P, Ellenbogen KA, et al. New-Onset left bundle branch block induced by transcutaneous aortic valve implantation. Am J Cardiol. 2016; 117(5): 867–873.
    CrossRefPubMed
  71. Nazif TM, Chen S, Kodali SK. Disarming the ticking time bomb: post-procedure electrocardiography predictors of high-degree conduction disturbances after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018; 11(15): 1527–1530.
    CrossRefPubMed
  72. Jørgensen TH, De Backer O, Gerds TA, et al. Immediate post-procedural 12-lead electrocardiography as predictor of late conduction defects after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018; 11(15): 1509–1518.
    CrossRefPubMed
  73. Rodés-Cabau J, Ellenbogen KA, Krahn AD, et al. Management of conduction disturbances associated with transcatheter aortic valve replacement: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019; 74(8): 1086–1106.
    CrossRefPubMed
  74. Krishnaswamy A, Sammour Y, Mangieri A, et al. The utility of rapid atrial pacing immediately post-tavr to predict the need for pacemaker implantation. JACC Cardiovasc Interv. 2020; 13(9): 1046–1054.
    CrossRefPubMed
  75. Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021; 42(35): 3427–3520.
    CrossRefPubMed
  76. Ream K, Sandhu A, Valle J, et al. Ambulatory rhythm monitoring to Detect Late high-grade atrioventricular block following transcatheter aortic valve replacement. J Am Coll Cardiol. 2019; 73(20): 2538–2547.
    CrossRefPubMed
  77. Houthuizen P, van der Boon RMA, Urena M, et al. Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation. EuroIntervention. 2014; 9(10): 1142–1150.
    CrossRefPubMed
  78. Mangieri A, Lanzillo G, Bertoldi L, et al. Predictors of advanced conduction disturbances requiring a late (≥48 h) permanent pacemaker following transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018; 11(15): 1519–1526.
    CrossRefPubMed
  79. Rodés-Cabau J, Urena M, Nombela-Franco L, et al. Arrhythmic burden as determined by ambulatory continuous cardiac monitoring in patients with new-onset persistent left bundle branch block following transcatheter aortic valve replacement: the MARE study. JACC Cardiovasc Interv. 2018; 11(15): 1495–1505.
    CrossRefPubMed
  80. Muntané-Carol G, Urena M, Nombela-Franco L, et al. Arrhythmic burden in patients with new-onset persistent left bundle branch block after transcatheter aortic valve replacement: 2-year results of the MARE study. Europace. 2021; 23(2): 254–263.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl